Coming Soon

Public Funding for Johnson & Johnson Limited

Registration Number 02175750

« Company Overview

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Genomic Main Phase - Early Diagnosis

12,500,000
2019-08-01 to 2020-03-31
Collaborative R&D
Awaiting Public Project Summary

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.